Avigen: Clinical Trials

6 trials sponsored by Avigen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 terminated. 4 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Terminated 1
Phase 24Terminated 3, Completed 1

Follow Avigen: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury
tolperisone HCl (AV650), Placebo - Muscle Spasticity
Phase 2TerminatedAvigen1202007-09-012008-11-04
Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis
tolperisone HCl - Muscle Spasticity
Phase 2TerminatedAvigen1502007-09-012008-11-04
AV650 Drug-Drug Interaction Study
AV650, Fluvoxamine, Paroxetine - Healthy
Phase 1CompletedAvigen302007-04-012007-09-17
Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain
AV411 - Diabetic Neuropathy
Phase 1 / Phase 2CompletedAvigen362006-09-012007-12-19
Study to Examine the Safety, Tolerability, and Pharmacokinetics of AV650
AV650 - Healthy Subjects
Phase 1CompletedAvigen302006-08-012007-02-28
Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B
Adeno-Associated Viral with Human Factor IX - Hemophilia B
Phase 1 / Phase 2TerminatedAvigen152004-01-012007-04-04

Conditions studied

Muscle Spasticity (2)  ·  Diabetic Neuropathies (1)  ·  Hemophilia B (1)  ·  Multiple Sclerosis (1)  ·  Spinal Cord Injuries (1)

Interventions

Tolperisone (2)  ·  Fluvoxamine (1)  ·  Paroxetine (1)  ·  ibudilast (1)

Countries

United States (4)  ·  Australia (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Russia (1)  ·  Serbia (1)  ·  Ukraine (1)

Top investigators

Glenn Morrison, MSc, PhD (1)  ·  Ralph J Marino, MD (1)  ·  Stephan A. Bart, M.D. (1)